Methodological Research for SDG Indicator 3.3.4: Hepatitis B Incidence per 100,000 population in the Philippines
Author: Bea Andrea C. Gavira, Dave Dianne O. Ludoc
Abstract:
Health is a fundamental component of sustainable development, as reflected in Sustainable Development Goal (SDG) 3, which aims to ensure healthy lives and promote well-being for all. Specifically, SDG Indicator 3.3.4 focuses on reducing the burden of hepatitis B by tracking its prevalence and guiding targeted interventions. Hepatitis B remains a global health challenge, particularly in highburden countries like the Philippines, where chronic liver disease and mortality are worsened by healthcare limitations and data gaps. This study develops a localized methodology for monitoring SDG Indicator 3.3.4 in the Philippines by reviewing international best practices, comparing local and global data sources, and analyzing case studies. The findings of the case studies highlight a high prevalence of hepatitis B across diverse population groups, including blood donors, pregnant women, healthcare workers, and highrisk groups such as seafarers and rural communities. Furthermore, the study found that the absence of a designated stakeholder for the SDG Indicator 3.3.4 monitoring hampers effective data collection and reporting. To address this, it recommends strengthening stakeholder coordination and expanding research accessibility. Enhanced surveillance, comprehensive screening, targeted vaccination programs, and policy interventions are essential to mitigating hepatitis B, closing data gaps, and supporting the Philippines’ progress toward achieving SDG Indicator 3.3.4.
Keywords: